Intervention

CONTROL GROUP

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting0

Common conditions7

Lead sponsors shown2

Clinical trials

2 shown

A Comparative Study of Pravastatin vs Placebo as Primary Prevention of Severe Subcutaneous Breast Fibrosis in Hyper-radiosensitive Identified Patients With Breast CancerNCT04385433 · 2020-12-04

Improvement of Physical and Physiological Parameters Through the Use of a Mobile AppNCT05093803 · 2020-07-01

Common conditions

Body Weight1 Breast Cancer1 Cholesterol; Lipidosis1 Diet, Healthy1 Hypertension1 Machine Learning1 Obesity1

Leading sponsors

Institut du Cancer de Montpellier - Val d'Aurelle1 University of Alicante1

Trial status mix

COMPLETED1

TERMINATED1

Phase mix

NA1

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.